Hepatitis B revaccination in healthy non-responder Chinese children: Five-year follow-up of immune response and immunologic memory

Vaccine

Volumn 24, Issue 12, 2006, Pages 2186-2192

  Zhuang, Gui Hua ^a   Yan, Hong ^a   Wang, Xue Liang ^a   Hwang, Lu Yu ^b   Wu, Qian ^a   Wang, Li Rong ^a   Gao, Hai Yan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepatitis B vaccine; Non responder; Revaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MALE; PRIORITY JOURNAL; REVACCINATION; SEROCONVERSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INJECTIONS, INTRADERMAL; MALE;

EID: 32844471309     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.004     Document Type: Article

References (48)

1. G.L. Xia, C.B. Liu, H.L. Cao, S.L. Bi, M.Y. Zhan, and C.A. Su Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China Int Hepatol Commun 5 1 1996 62 73
2. Z.T. Sun, L.H. Ming, X. Zhu, and J.H. Lu Prevention and control of hepatitis B in China J Med Virol 67 3 2002 447 450
3. C. Seeger, and W.S. Mason Hepatitis B virus biology Microbiol Mol Biol Rev 64 1 2000 51 68
4. D.R. Milich Immune response to the hepatitis B virus: infection, animal models, vaccination Viral Hepat Rev 3 1997 63 103
5. European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 355 9203 2000 561 565
6. J.E. Banatvala, and P. Van Damme Hepatitis B vaccine - do we need boosters? J Viral Hepat 10 1 2003 1 6
7. R.S. Koff Immunogenicity of hepatitis B vaccines: implications of immune memory Vaccine 20 31-32 2002 3695 3701
8. A. Amani, and F. Shokri Immunogenicity of a recombinant hepatitis B vaccine in Iranian neonates: high frequency of unresponsiveness independent of the carrier state of mothers Irn J Med Sci 20 1-2 1995 87 92
9. P. Rendi-Wagner, M. Kundi, H. Stemberger, G. Wiedermann, H. Holzmann, and M. Hofer Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience Vaccine 19 15-16 2001 2055 2060
10. T. Coates, R. Wilson, G. Patrick, F. André, and V. Watson Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines Clin Ther 23 3 2001 392 403
11. A.D. Jack, A.J. Hall, N. Maine, M. Mendy, and H.C. Whittle What level of hepatitis B antibody is protective? J Infect Dis 179 2 1999 489 492
12. S.C. Hadler, D.P. Francis, J.E. Maynard, S.E. Thompson, F.N. Judson, and D.F. Echenberg Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men N Engl J Med 315 4 1986 209 214
13. H. Whittle, S. Jaffar, M. Wansbrough, M. Mendy, U. Dumpis, and A. Collinson Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children BMJ 325 7364 2002 569 573
14. D.R. Milich, G.B. Thornton, A.R. Neurath, S.B. Kent, M.L. Michel, and P. Tiollais Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen Science 228 4707 1985 1195 1199
15. D.R. Milich, A. McLachlan, F.V. Chisari, S.B. Kent, and G.B. Thorton Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1) specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of the HBsAg J Immunol 137 1 1986 315 322
16. B. Yerushalmi, R. Raz, O. Blondheim, E. Shumov, R. Koren, and R. Dagan Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates Pediatr Infect Dis J 16 6 1997 587 592
17. I. Yap, R. Guan, and S.H. Chan Study on the comparative immunogenicity of a recombinant DNA vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines J Gastroenterol Hepatol 10 1 1995 51 55
18. C.P. Eyigün, S. Yilmaz, C. Gül, A. Sengül, A. Hacibektasoglu, and D.H. Van Thiel A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults J Viral Hepat 5 4 1998 265 269
19. J.S. Bertino Jr., P. Tirrell, R.N. Greenberg, H.L. Keyserling, G.A. Poland, and D. Gump A comparative trial of standard of high-dose S subunit recombinant hepatitis B vaccine versus a vaccine containing S subunit, pre-S1 and pre-S2 particles for revaccination of healthy adult nonresponders J Infect Dis 175 3 1997 678 681
20. C.O. Tacket, M.J. Roy, G. Widera, W.F. Swain, S. Broome, and R. Edelman Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device Vaccine 17 22 1999 2826 2829
21. S.T. Rottinghaus, G.A. Poland, R.M. Jacobson, L.J. Barr, and M.J. Roy Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination Vaccine 21 31 2003 4604 4608
22. P. Rendi-Wagner, G. Wiedermann, H. Stemberger, and H. Kollaritsch New vaccination strategies for low- and non-responders to hepatitis B vaccine Wien Klin Wochenschr 114 5-6 2002 175 180
23. W. Jilg Novel hepatitis B vaccines Vaccine 16 Suppl 1998 S65 S68
24. K. Cichutek DNA vaccines: development, standardization and regulation Intervirology 43 4-6 2000 331 338
25. M.R. Hilleman Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus Vaccine 21 32 2003 4626 4649
26. G.A. Poland Hepatitis B immunization in health care workers dealing with vaccine non-response Am J Prev Med 15 1 1998 73 77
27. The Centers for Disease Control Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR 40 RR-13 1991 1 19
28. K.F. Cheng, M.H. Chang, C.Y. Lee, L.M. Huang, H.Y. Hsu, and P.I. Lee Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in health non-responding children Vaccine 12 10 1994 899 902
29. C. Belloni, C. Tinelli, P. Orsolini, A. Pistorio, A. Avanzini, and A. Moretta Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth A parallel evaluation of rubella and tetanus vaccine Vaccine 16 4 1998 399 402
30. F. Shokri, and A. Amani High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonates Med Microbiol Immunol 185 4 1997 231 235
31. P. Wismans, J. van Hattum, T. Stelling, J. Poel, and G.C. de Gast Effect of supplementary vaccination in healthy non-responders to hepatitis B vaccination Hepatogastroenterology 35 2 1988 78 79
32. J. Struve, B. Aronsson, B. Frenning, M. Forsgren, and O. Weiland Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine Scand J Infect Dis 26 4 1994 468 470
33. F. Averhoff, F. Mahoney, P. Coleman, G. Schatz, E. Hurwitz, and H. Margolis Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus infection Am J Prev Med 15 1 1998 1 8
34. M. Chiaramonte, T. Ngatchu, S. Majori, V. Baldo, M.E. Moschen, and G. Renzulli Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization Scand J Gastroenterol 30 6 1995 601 603
35. K.L. Tan, K.T. Goh, C.J. Oon, and S.H. Chan Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization JAMA 271 11 1994 859 861
36. F. Fabrizi, S. Andrulli, G. Bacchini, M. Corti, and F. Locatelli Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation Nephrol Dial Transplant 12 6 1997 1204 1211
37. F. Rahman, A. Dahmen, S. Herzog-Hauff, W.O. Böcher, P.R. Galle, and H.F. Löhr Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen Hepatology 31 2 2000 521 527
38. E.G. Playford, P.G. Hogan, A.S. Bansal, K. Harrison, D. Drummond, and D.F. Looke Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine Infect Control Hosp Epidemiol 23 2 2002 87 90
39. Z.L. Liang, C.M. Li, Q. Jing, Z. Xiang, C.M. Yang, and L.J. Ren Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children Chin J Prevent Med 32 3 1998 165 167
40. Z.L. Liang, H.M. Li, X.Y. Wu, Y.P. Li, G.Z. Zhao, and R.C. Li A study of interrupting mother-to-infant transmission of hepatitis B virus using different recombinant hepatitis B vaccines in China Chin J Prevent Med 2 4 2001 275 277
41. G.M. Keating, and S. Noble Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B Drugs 63 10 2003 1021 1051
42. World Health Organization. Hepatitis B. Geneva: WHO/CDS/CSR/LYO/2002.2: Hepatitis B:54.
43. D.R. Milich, and G.G. Leroux-Roels Immunogenetics of the response to HBsAg vaccination Autoimmun Rev 2 5 2003 248 257
44. T. Höhler, E. Reuss, N. Evers, E. Dietrich, C. Rittner, and C.M. Freitag Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins Lancet 360 9338 2002 991 995
45. J.P. Bryan, P.G. Craig, L. Reyes, S. Hakre, R. Jaramillo, and H. Harlan Randomized comparison of 5 and 10 μg doses of two recombinant hepatitis B vaccines Vaccine 13 11 1995 978 982
46. R.E. Vryheid, M.A. Kane, N. Muller, G.C. Schatz, and S. Bezabeh Infant and adolescent hepatitis B immunization up to 1999: a global overview Vaccine 19 9-10 2001 1026 1037
47. P. Beutels Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000) Health Econ 10 8 2001 751 774
48. L.A. Moyer, and E.E. Mast Hepatitis A through E J Intraven Nurs 21 5 1998 286 290